Drug intelligence / Profile preview

mixture of modified allergen extracts of 6 grasses + modified allergen extract of olive pollen

Development stage
Unknown
Lead developer
Inmunotek
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

The mixture of modified allergen extracts of 6 grasses + modified allergen extract of olive pollen is a subcutaneous allergen immunotherapy (SCIT) product developed by Inmunotek S.L. It is a polymerized allergoid formulation created by glutaraldehyde modification of extracts from six grass species (*Holcus lanatus*, *Dactylis glomerata*, *Lolium perenne*, *Phleum pratense*, *Poa pratensis*, and *Festuca elatior*) and olive tree (*Olea europaea*) pollen. This chemical modification reduces the IgE-binding capacity of the allergens, thereby minimizing the risk of systemic allergic reactions (anaphylaxis) during administration, while preserving their immunogenicity to induce protective IgG antibodies and T-cell tolerance. The drug is intended for patients co-sensitized to both grass and olive pollens who suffer from moderate-to-severe allergic rhinitis, rhinoconjunctivitis, and/or controlled mild-to-moderate asthma.

Other names
MG01 + T517polymerized grass and olive pollen allergoidsInmunotek grass and olive SCIT
02

Targets

IgE (Immunoglobulin E)γδ TCR (T-cell receptor)

Beyond the preview

Go deeper on mixture of modified allergen extracts of 6 grasses + modified allergen extract of olive pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mixture of modified allergen extracts of 6 grasses + modified allergen extract of olive pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call